Dr. Reddy’s Settles Revlimid Patent Litigation
On September 17, Bristol Myers Squibb (Celgene) announced the settlement of U.S. patent litigation for revlimid (lenalidomide) with Dr. Reddy’s (Dr. Reddy’s Laboratories Ltd.). Originally,…
On September 17, Bristol Myers Squibb (Celgene) announced the settlement of U.S. patent litigation for revlimid (lenalidomide) with Dr. Reddy’s (Dr. Reddy’s Laboratories Ltd.). Originally,…
Medicare and its beneficiaries could have spared an assumed $17.7 billion over a seven-year time frame on traditional forms of older medicines as opposed to…
EpiPen is one of the most effective and expensive solutions developed to save the lives of people who have severe allergic reactions (anaphylaxis). It’s manufactured…
In March 1998, Pfizer Inc. launched the first pill for impotence that became very popular after early TV advertisement and turned erectile dysfunction (ED) into…
Sometimes patients could notice the next line in their prescription: “dispense as written”. It means pharmacist should fill the prescription with a brand-name drug (which…
Since 2008, rough economy situation pushed consumers to buy more generic medications than brand-name alternatives because of their lower price. And often consumers hear, that…
Wolters Kluwer Pharma Solutions, Inc. released the results of a new Insight study. Pharma Solutions is a one of the leaders in collecting data in…